APRINOIA Therapeutics Appoints Mark S. Shearman, Ph.D., as Chief Executive Officer
August 28, 2023 11:00 ET
|
APRINOIA Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics (“APRINOIA”), a global clinical-stage biopharmaceutical company developing novel therapeutics and precision diagnostics for...
Skout’s Honor Continues Rapid Team Expansion to Support Growing Consumer Demand
September 02, 2021 08:00 ET
|
Skout's Honor
Oceanside, CALIFORNIA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Throughout the global pandemic and in response to many searching for companionship during this time, the pet industry experienced an...